Europe Interventional Oncology Device Market Snapshot
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging clinical data supporting ablation and embolization procedures as standard-of-care treatments. Increasing preference for minimally invasive procedures over surgery, improved reimbursement, and physician acceptance will drive adoption. However, growth will be hindered by mixed clinical data, pricing pressures, and regional cost constraints.
Read our Market Snapshot to access data and analysis on the state of the market for interventional oncology devices in Europe from 2019 to 2034.